GlassScriptPhysician profile
Scott F Lopez
NPI 1538268065
$1,780.11
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $461 · 2022: $388 · 2023: $812 · 2024: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $424.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $535.20 | 2021-2023 | |
| Abbvie INC. | $402.35 | 2023 | |
| Boston Scientific Corporation | $144.21 | 2021-2024 | Varithena Administration Pack |
| Abbott Laboratories | $109.82 | 2022-2023 | Gallant, Jot Dx |
| Janssen Pharmaceuticals, INC | $76.06 | 2022-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $67.57 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $61.52 | 2021 | |
| Angiodynamics, INC. | $61.05 | 2021-2024 | Auryon Laser System 100-120 Vac |
| Edwards Lifesciences Corporation | $46.91 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kiniksa Pharmaceuticals, LTD. | $45.03 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $23.96 | 2024 | |
| Impulse Dynamics (USA) INC. | $23.49 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.34 | 2023 | Lifevest |
| Scpharmaceuticals INC. | $22.03 | 2023 | |
| Bard Peripheral Vascular, INC. | $21.37 | 2023 | Venclose Maven Catheter |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $20.05 | 2023 | Injectafer |
| Novartis Pharmaceuticals Corporation | $18.04 | 2024 | |
| Sanofi-Aventis U.S. LLC | $17.71 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $16.80 | 2023 | Opsumit |
| Alnylam Pharmaceuticals INC. | $15.87 | 2023 | Amvuttra |
| Pfizer INC. | $15.71 | 2024 | |
| Astellas Pharma US INC | $13.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.